Results 41 to 50 of about 6,104 (218)

Small Molecule Analysis of Extracellular Vesicles Produced by Cryptococcus gattii: Identification of a Tripeptide Controlling Cryptococcal Infection in an Invertebrate Host Model

open access: yesFrontiers in Immunology, 2021
The small molecule (molecular mass <900 Daltons) composition of extracellular vesicles (EVs) produced by the pathogenic fungus Cryptococcus gattii is unknown, which limits the understanding of the functions of cryptococcal EVs.
Flavia C. G. Reis   +7 more
doaj   +1 more source

Cryptococcus neoformans var. gattii in Australia [PDF]

open access: yesJournal of Clinical Microbiology, 1987
An examination of 45 clinical isolates of Cryptococcus neoformans revealed an unusually high incidence of C. neoformans var. gattii in South Australia (65%) and in the Northern Territory (95%). In assessing all the available data from Australian isolates of C. neoformans, there appeared to be an endemic focus for the incidence of C.
openaire   +2 more sources

Pulmonary cryptococcal infection presenting with multiple lung nodules

open access: yesRespiratory Medicine Case Reports, 2018
Pulmonary infections from the environmental fungus Cryptococcus gattii (C. gattii) are notable for cryptococcomas, which are usually solitary and can be very large. As with infections with Cryptococcus neoformans (C.
Thilini L. Basnayake   +2 more
doaj   +1 more source

Gene, virulence and related regulatory mechanisms in Cryptococcus gattii

open access: yesActa Biochimica et Biophysica Sinica, 2022
Cryptococcus gattii is a kind of basidiomycetous yeast, which grows in human and animal hosts. C. gattii has four distinct genomes, VGI/AFLP4, VGII/AFLP6, VGIII/AFLP5, and VGIV/AFLP7. The virulence of C.
Huang Yemei   +8 more
doaj   +1 more source

Population Genetic Analysis Reveals a High Genetic Diversity in the Brazilian Cryptococcus gattii VGII Population and Shifts the Global Origin from the Amazon Rainforest to the Semi-arid Desert in the Northeast of Brazil. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2016
Cryptococcus neoformans and Cryptococcus gattii are responsible globally for almost one million cryptococcosis cases yearly, mostly in immunocompromised patients, such as those living with HIV. Infections due to C.
Ana C P Souto   +17 more
doaj   +1 more source

Cryptococcus gattii, Florida, USA, 2011

open access: yesEmerging Infectious Diseases, 2013
To the Editor: Cryptococcosis is a systemic mycosis most commonly caused by 2 species of encapsulated yeast: Cryptococcus neoformans and C. gattii. C. gattii is a globally emerging pathogen. In the United States, an outbreak of C. gattii infection caused by molecular type VGII has been ongoing since 2004, primarily in the Pacific Northwest (1).
Rajesh Kunadharaju   +4 more
openaire   +2 more sources

Fatal Outcome due to Disseminated Cryptococcosis in a Patient With HIVrequiring Veno‐Arterial Extracorporeal Membrane Oxygenation: A Case Report

open access: yesAcute Medicine &Surgery, Volume 13, Issue 1, January/December 2026.
This report details a fatal case of fulminant disseminated cryptococcosis in a young male with undiagnosed HIV. He rapidly developed multi‐organ failure, refractory shock, and cardiac arrest. Autopsy revealed extensive myocardial cryptococcal infiltration and microemboli, suggesting a critical role in the acute refractory shock that led to his death ...
Taisei Sasamoto   +3 more
wiley   +1 more source

AIDS Patient Death Caused by Novel Cryptococcus neoformans × C. gattii Hybrid

open access: yesEmerging Infectious Diseases, 2008
Interspecies hybrids of Cryptococcus neoformans and C. gattii have only recently been reported. We describe a novel C. neoformans × C. gattii hybrid strain (serotype AB) that was previously described as C.
Marjan Bovers   +6 more
doaj   +1 more source

Projecting Global Occurrence ofCryptococcus gattii

open access: yesEmerging Infectious Diseases, 2010
Cryptococcus gattii and C. neoformans cause pulmonary and systemic cryptococcosis. Recently, C. gattii was recognized as a distinct pathogen of humans and animals. We analyzed information from 400 publications (1948-2008) to examine whether the fungus occurs globally. Known distribution of C.
Deborah J. Springer, Vishnu Chaturvedi
openaire   +3 more sources

Could the Biological Potency of Porcelia macrocarpa R.E. Fries (Annonaceae) be Linked to Its Diverse Metabolite Profile?

open access: yesChemistry &Biodiversity, Volume 23, Issue 1, January 2026.
ABSTRACT Porcelia macrocarpa is a Brazilian plant species belonging to the Annonaceae family. To date, more than 190 compounds have been identified and/or isolated from this species, with terpenoids comprising the majority (62%). Alkaloids represent the second most abundant class (11%), followed by steroids (4%), acetogenins (4%), fatty acids (4 ...
Fernanda Thevenard   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy